DGAP-News: DEMIRE Deutsche Mittelstand Real Estate AG / Key word(s): Capital Increase/Corporate Action DEMIRE Deutsche Mittelstand Real Estate AG: Annual General Meeting supplies the means for future growth 10.03.2015 / 12:09 --------------------------------------------------------------------- DEMIRE Annual General Meeting supplies the means for future growth - Extraordinary Annual General Meeting resolves new capital - Development into a leading holder of real estate in Germany Frankfurt/Main, 10 March 2015 - At the Extraordinary Annual General Meeting of DEMIRE Deutsche Mittelstand Real Estate AG ("DEMIRE", ISIN DE000A0XFSF0) held on 6 March 2015, the shareholders approved the proposals of the management with regard to the capital measures planned with a large majority, thereby creating the means for continued growth. The real estate group can now continue with the expansion of its commercial real estate portfolio. After growing strongly in the past several months, DEMIRE has developed into a leading holder in the German commercial real estate market. Specifically, the Extraordinary Annual General Meeting resolved the creation of new authorised capital amounting to EUR 8.54 million for a total of available authorised capital of EUR 9.97 million. Through the creation of additional conditional capital in the amount of EUR 2.43 million to grant subscription and conversion rights for debentures issued and in the amount of EUR 1.00 million for a stock option plan for the Executive Board and employees, conditional capital increased to a total of EUR 9.97 million. Also at the Annual General Meeting, Dr Peter Maser was elected to the Supervisory Board. The authorised capital recently approved by the Annual General Meeting in October 2014, had already been largely utilised in January 2015 due to the acquisition of a real estate portfolio in return for the issue of shares. The new authorised capital will allow the Company to use further shares as consideration for acquisitions of commercial real estate in the future. Andreas Steyer, Speaker of the Board of Directors commented: "With this vote from our shareholders, we can continue to pursue our growth path. Our pipeline is filled with properties that display an interesting investment profile". The Executive Board About DEMIRE Deutsche Mittelstand Real Estate DEMIRE Deutsche Mittelstand Real Estate AG is a Frankfurt/Main headquartered real estate Group with a clear focus on commercial real estate in Germany. The Group pursues a buy-and-hold-strategy combined with active portfolio management. It is concentrated on both the value-added and core-plus investment approaches. The combination of these two approaches offers a balanced risk-return ratio and attractive opportunities. The shares of DEMIRE Deutsche Mittelstand Real Estate AG (ISIN DE000A0XFSF0) are listed in the regulated market (General Standard Segment) of the Frankfurt Stock Exchange. Contact DEMIRE Deutsche Mittelstand Real Estate AG Lyoner StraÃe 32 60528 Frankfurt am Main Phone: +49 (0) 69-719 189 79 0 Telefax: +49 (0) 69-719 189 79 11 Email: ir@demire.ag Web: www.demire.ag Investor Relations GFEI Aktiengesellschaft Lars Kuhnke Phone: +49 (0) 511 4740 2310 Email: ir@demire.ag --------------------------------------------------------------------- 10.03.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: DEMIRE Deutsche Mittelstand Real Estate AG Lyoner StraÃe 32 60528 Frankfurt am Main Germany Phone: +49 (0)69 / 719 189 79 0 Fax: +49 (0)69 / 719 189 79 11 E-mail: info@demire.ag Internet: www.demire.ag ISIN: DE000A0XFSF0 WKN: A0XFSF Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 331761 10.03.2015
DGAP-News: DEMIRE Deutsche Mittelstand Real Estate AG:
Top 10 Most Recent News Articles
LA Hospitals Shine in Pulmonary Excellence Nationwide
Los Angeles Community Hospitals' Recent Recognition You ever stroll into a hospital and wonder if you’re really getting the best care? Well, the folks over at Los Angeles Community Hospitals, covering LA, Norwalk, and Bellflower, just got a big nod from Healthgrades—yeah, the site everyone's checking to find decent healthcare options. They’ve landed among the top...
Continue Reading
Pinot's Palette Expands with New La Quinta Studio
Canvas and Cabernet in Coachella Valley Grab your brushes and wine glasses; Pinot's Palette is branching out to La Quinta. As of November 27, locals and visitors alike can find their artistic flair at 47120 Dune Palms Road. This move isn’t just another business expansion—it's about blending community spirit with creativity, backed by the experienced entrepreneurs...
Continue Reading
A&G Management's Bold New Era with WPM Partnership
Shaking Up Baltimore's Real Estate Scene Swapping up management partners can be a dicey game, but A&G Management seems to be pulling it off without a hitch. As of January 4, 2027, WPM Real Estate Management will take over the reins for more than 3,000 apartment homes scattered across Anne Arundel, Howard, and Baltimore counties. A new set of hands is stepping in for...
Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut
A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...
Continue Reading
Rakuten Medical Fires Up Phase 1 Trial for RM-0256 Therapy
Taking Aim at Refractory Tumors in Japan Get this—Rakuten Medical is stepping into the ring with their new cancer-busting tactic, RM-0256 photoimmunotherapy, right in Japan. We're talking about a Phase 1 trial that'll throw a new kind of punch at solid tumors, specifically targeting troublesome skin cancers that don’t seem to play nice with current treatments. Now,...
Continue Reading
Austin Rattler Event Revamps With Two-Day Off-Road Bash
Austin's Off-Road Bash Kicks Up Dust in Hill Country It's not just another grind in the biking and running world; the Life Time Austin Rattler's gone off the reservation pushing the pedals and the pace across the rugged terrain of Texas Hill Country. Here's to muscles burning and soles slapping the dirt for two straight days, all in the name of challenging nature's best....
Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026
An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...
Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again
Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...
Continue Reading
Kinross Gold Faces Class Action Over Misleading Forecasts
A Golden Opportunity Gone Wrong Well, it looks like Kinross Gold Corporation (NYSE: KGC) has stuck its foot in it again. This time, they're in hot water over claims that don't exactly hold up under scrutiny. If you're holding KGC, you've probably heard about the fresh class action lawsuit alleging they misled investors about their production targets. Naturally, the...
Continue Reading
Tigo Energy Faces Lawsuit: Key Details for Investors
Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...
Continue ReadingTop 5 Most Recently Viewed Articles
GIGABYTE Unveils Compact NVIDIA GeForce RTX 50 Series GPUs
GIGABYTE Shines at CES with Revolutionary Graphics Card Launch The latest unveiling from GIGABYTE, a leader in innovative computer hardware, features their NVIDIA GeForce RTX™ 50 Series graphics cards. These models, including the GeForce RTX™ 5090, RTX™ 5090 D, RTX™ 5080, RTX™ 5070 Ti, and RTX™ 5070, promise to elevate gaming and creative experiences...
Continue Reading
EssilorLuxottica's Strategic Share Buyback Announcement Details
EssilorLuxottica: Share Buyback Update Disclosure of transactions in own shares EssilorLuxottica has recently informed the public about its share buyback activities, following the authorization from its Annual Shareholders’ Meeting held on April 30, 2024. This initiative reflects the company's commitment to maintaining a healthy and robust stock market presence. Recent...
Continue Reading
Aker BP Announces Ex-Dividend Payment of USD 0.63 Today
Understanding Aker BP's Ex-Dividend Payment Aker BP ASA has officially announced that its shares will commence trading ex-dividend today, marking a significant moment for investors. The ex-dividend amount is set at USD 0.63 per share, equivalent to NOK 6.36193. This announcement is crucial for shareholders looking to understand their financial returns from this reputable...
Continue Reading
PL Developments Secures FDA Nod for Omeprazole and Debt Restructure
PL Developments Reaches Major Milestones With FDA Approval PL Developments (PLD), a leader in the healthcare sector, recently announced two substantial achievements: the FDA's approval for its Omeprazole OTC ANDA and the successful refinancing of its corporate debt. These milestones mark significant advancements in the company's ongoing efforts to innovate and grow....
Continue Reading
Akari Therapeutics Gears Up for Innovations in ADC Payloads
Akari Therapeutics Gears Up for Innovations in ADC Payloads Akari Therapeutics, Plc (NASDAQ: AKTX), is making strides in the oncology biotechnology field, particularly with its progressive advancements in antibody drug conjugates (ADCs). Recently, the company released an insightful segment of the CEO Corner, which provides a comprehensive update on its initiatives and...
Continue Reading